Percutaneous closure has evolved to become the first-line treatment strategy for most cases
of secundum atrial septal defect (ASD) in both adults and children. Its safety and efficacy …

Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen
Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography …

Objectives: This study sought to compare the safety, efficacy and clinical utility of the
Amplatzer septal occluder (ASO) for closure of secundum atrial septal defect (ASD) with …

Objectives: The aim of this study was to assess long-term results of percutaneous closure of
secundum-type atrial septal defect (ASD II) using Amplatzer septal occluders (ASO) …

Atrial septal defect (ASD) is one of the most common congenital heart defects, accounting for
7%-10% of all congenital heart disease (CHD) in children and 30%-33% of defects …

Background—The use of permanent synthetic implants to close atrial septal defects (ASD)
and patent foramen ovale (PFO) has a number of limitations, including late complications …

Using an Amplatzer membranous eccentric occluder, 186 patients with an average weight of
43.5 kg (range 12.5–77) underwent attempted catheter closure of a perimembranous …

Objectives: We sought to determine the incidence, nature, and predisposing factors of
atrioventricular block (AVB) associated with closure of atrial septal defects (ASDs) using the …

Background: The clinical efficacy of transcatheter atrial septal defect (ASD) closure with the
Amplatzer Septal Occluder (ASO) can only be judged against the results of …

Atrial septal defects (ASD) are among the most common forms of congenital heart disease
accounting for 10% of all defects. Until now, surgical closure was considered the sole …